☆ 4.2 Article

Utility and Limitations of Addenbrooke's Cognitive Examination-Revised for Detecting Mild Cognitive Impairment in Parkinson's Disease

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2011)

Journal

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Volume 31, Issue 5, Pages 349-357

Publisher

KARGER

DOI: 10.1159/000328165

Keywords

Addenbrooke's cognitive examination; Dementia; Mild cognitive impairment; Parkinson's disease; Screening

Categories

Geriatrics & Gerontology Clinical Neurology Psychiatry

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

Background/Aims: To evaluate the utility of the Addenbrooke's Cognitive Examination-Revised (ACE-R) as a screening tool for mild cognitive impairment in Parkinson's disease (PD-MCI). Methods: PD patients underwent comprehensive neuropsychological and neurological evaluations and ACE-R assessment. Results: The ACE-R was superior to the Mini-Mental State Exam (MMSE) in detecting PD-MCI, with a cutoff score of <= 93 offering a sensitivity of 61% and a specificity of 64%. The utility of the ACE-R in detecting PD-MCI is largely influenced by the fluency sub-domain score, and has optimal discriminability when utilized in patients with lower levels of education (<= 12 years of formal schooling). Conclusion: The ACE-R must be used cautiously as a screening tool for PD-MCI, with results being most influenced by its fluency sub-domain score and patient education levels. Copyright (C) 2011 S. Karger AG, Basel

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

Article Clinical Neurology

Adaption and preliminary validation of the Addenbrooke's Cognitive Examination-III as a screening test for mild cognitive impairment and dementia in hearing-impaired individuals

Courtney North, Mary H. Heatley, Nattawan Utoomprurkporn, Doris Eva Bamiou, Sergi G. Costafreda, Joshua Stott

Summary: The study developed a hearing-impaired version of the Addenbrooke's Cognitive Examination-III (HI-ACE-III) and found that it can accurately distinguish people with mild cognitive impairment (MCI) and dementia. The HI-ACE-III showed good reliability, validity, and screening utility for older adults with hearing impairments.

EUROPEAN JOURNAL OF NEUROLOGY (2021)

Add to Collection

Review Clinical Neurology

Cognitive assessment tools for mild cognitive impairment screening

Lei Zhuang, Yan Yang, Jianqun Gao

Summary: Mild cognitive impairment (MCI) is a clinical condition with a high risk of progressing to dementia. Early diagnosis and intervention at the MCI stage are considered critical strategies in disease management. Lack of consensus on guidelines for routine screening of MCI leads to a considerable number of undiagnosed patients in the community.

JOURNAL OF NEUROLOGY (2021)

Add to Collection

Article Behavioral Sciences

Validation of a modified Chinese version of Mini-Addenbrooke's Cognitive Examination for detecting mild cognitive impairment

Feng-Feng Pan, Liang Cui, Qing-Jie Li, Qi-Hao Guo

Summary: A modified Chinese version of Mini-Addenbrooke's Cognitive Examination (C-MACE) was developed and showed good classification accuracy in detecting MCI. C-MACE performed best in identifying MCI in older individuals with lower education levels.

BRAIN AND BEHAVIOR (2022)

Add to Collection

Review Geriatrics & Gerontology

Mild cognitive impairment in patients with Parkinson's disease: An updated mini-review and future outlook

Rwei-Ling Yu, Ruey-Meei Wu

Summary: Mild cognitive impairment (MCI) is a common non-motor symptom in patients with Parkinson's disease (PD), but lacks consistent diagnostic criteria. Different types of cognitive impairments have different progression rates. This review provides an overview of the diagnostic criteria for PD-MCI and the heterogeneity of patients' cognitive function.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Add to Collection

Article Psychology, Multidisciplinary

FDG-PET-based neural correlates of Addenbrooke's cognitive examination III scores in Alzheimer's disease and frontotemporal degeneration

Maria Nieves Cabrera-Martin, Pedro Nespral, Maria Valles-Salgado, Pablo Bascunana, Cristina Delgado-Alonso, Alfonso Delgado-Alvarez, Lucia Fernandez-Romero, Juan Ignacio Lopez-Carbonero, Maria Diez-Cirarda, Maria Jose Gil-Moreno, Jorge Matias-Guiu, Jordi A. Matias-Guiu

Summary: This study investigated the metabolic correlates associated with the performance of ACE-III in Alzheimer's disease (AD) and frontotemporal dementia (FTD). The results showed distinct neural correlates for ACE-III in bvFTD and AD, with lower scores associated with more advanced stages in both disorders. ACE-III exhibited high discrimination between bvFTD vs. HC and AD vs. HC. It was also sensitive to detect hypometabolism in brain regions associated with bvFTD and AD.

FRONTIERS IN PSYCHOLOGY (2023)

Add to Collection

Article Clinical Neurology

Toward rational use of cognitive training in those with mild cognitive impairment

Benjamin M. Hampstead, Anthony Y. Stringer, Alexandru D. Iordan, Robert Ploutz-Snyder, K. Sathian

Summary: Cognitive training is a potential technique for treating cognitive impairment caused by neurological injury and disease. Different training methods have different mechanisms of action and engage distinct brain regions. Mnemonic strategy training (MST) showed superior effects in the short term and increased activation and functional connectivity in multiple brain regions.

ALZHEIMERS & DEMENTIA (2023)

Add to Collection

Article Neurosciences

Everyday Function in Alzheimer's and Parkinson's Patients with Mild Cognitive Impairment

Sara Becker, Olga Boettinger, Patricia Sulzer, Markus A. Hobert, Kathrin Brockmann, Walter Maetzler, Daniela Berg, Inga Liepelt-Scarfone

Summary: Through FAQ assessment, it was found that PD-MCI patients had more difficulties with tax records and traveling, while AD-MCI patients were more impaired in managing finances and remembering appointments. The classification accuracy of the FAQ differed between MCI related to PD and AD.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Add to Collection

Editorial Material Cell Biology

Can mild cognitive impairment and Alzheimer's disease be diagnosed by monitoring a miRNA triad in the blood?

Zhuang-Yao D. Wei, Ashok K. Shetty

Summary: This article discusses a recent study that suggests using a miRNA triad, consisting of miR-181a-5p, miR-146a-5p, and miR-148a-3p, for diagnosing ACI, MCI, and AD. The study explores the impact of elevated levels of this miRNA triad on neural plasticity and cognitive function in the brain and the potential of inhibiting it to improve cognitive function in MCI and AD.

AGING CELL (2022)

Add to Collection

Review Biochemistry & Molecular Biology

Neutrophil-Mediated Progression of Mild Cognitive Impairment to Dementia

Kyoungjoo Cho

Summary: Cognitive impairment is a serious condition associated with aging and disruption of inflammation and innate immunity. Recent studies have shown that the innate immune system is prevalent in patients with Alzheimer's disease, and peripheral neutrophil markers can predict a decline in cognitive function in patients with mild cognitive impairment. Furthermore, altered levels of pro-inflammatory interleukins have been reported in patients with mild cognitive impairment, potentially playing a role in the progression from early cognitive impairment to dementia.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Add to Collection

Article Geriatrics & Gerontology

A New Instrument Combines Cognitive and Social Functioning Items for Detecting Mild Cognitive Impairment and Dementia in Parkinson's Disease

Ya-Wen Yu, Chun-Hsiang Tan, Hui-Chen Su, Chung-Yao Chien, Pi-Shan Sung, Tien-Yu Lin, Tsung-Lin Lee, Rwei-Ling Yu

Summary: The study aimed to simplify commonly used tools and combine cognitive and social functioning tests to detect early MCI and PDD. According to MDS diagnostic criteria, patients were grouped into PD nonMCI, PD-MCI, or PDD.

FRONTIERS IN AGING NEUROSCIENCE (2022)

Add to Collection

Article Clinical Neurology

The epidemiology of mild cognitive impairment, Alzheimer's disease and related dementia in US veterans

Deepika Dinesh, Qing Shao, Madhuri Palnati, Sarah McDannold, Quanwu Zhang, Amir Abbas Tahami Monfared, Guneet K. Jasuja, Heather Davila, Weiming Xia, Lauren R. Moo, Donald R. Miller, Natalia Palacios

Summary: Based on electronic health records data, a study found that US veterans have a unique dementia risk profile that may be changing over time. From 2000 to 2019, the incidence and prevalence of Alzheimer's disease (AD) and related dementias (ADRD) decreased, while ADRD prevalence increased primarily due to an increase in dementia not otherwise specified. The prevalence and incidence of mild cognitive impairment (MCI) sharply increased, especially after 2010. The highest prevalence and incidence of AD, ADRD, and MCI were observed in the oldest veterans, female veterans, and African American and Hispanic veterans.

ALZHEIMERS & DEMENTIA (2023)

Add to Collection

Article Psychology, Multidisciplinary

Psychometric properties and construct validity of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS) in Colombia

Hugo Juan Camilo Clavijo-Moran, Daniela Alvarez-Garcia, Gabriel D. Pinilla-Monsalve, Beatriz Munoz-Ospina, Jorge Orozco

Summary: This study investigated the cognitive assessment scale for patients with Parkinson's disease in the Colombian population and found that the Parkinson's Disease Cognitive Rating Scale (PD-CRS) has acceptable psychometric properties and significant correlation and agreement with another validated scale (MoCA).

FRONTIERS IN PSYCHOLOGY (2022)

Add to Collection

Review Health Care Sciences & Services

Utility of Chinese Versions of Addenbrooke's Cognitive Examination: A Narrative Review

Ling-Xiao Cao, Gang Wang, Qi-Hao Guo, Wei Zhang, Thomas Bak, Yue Huang

Summary: Addenbrooke's cognitive examination (ACE) is an effective cognitive screening tool that shows better performance than other tests in detecting mild cognitive impairment in various neurological disorders. The Chinese version of ACE has been translated into multiple languages and can facilitate early identification and management of cognitive impairment in China.

HEALTHCARE (2022)

Add to Collection

Article Clinical Neurology

Cognitive impairment and dementia in young onset Parkinson's disease

Teresa de Deus Fonticoba, Carlos Cores Bartolome, Maria J. Feal Painceiras, Iago Garcia Diaz, Maria Cristina iniguez Alvarado, Jose Manuel Paz, Silvia Jesus, Marina Cosgaya, Juan Garcia Caldentey, Nuria Caballol, Ines Legarda, Jorge Hernandez Vara, Iria Cabo, Lydia Lopez Manzanares, Isabel Gonzalez Aramburu, Maria A. avila Rivera, Victor Gomez Mayordomo, Victor Nogueira, Julio Dotor Garcia-Soto, Carmen Borrue, Berta Solano Vila, Maria alvarez Sauco, Lydia Vela, Sonia Escalante, Esther Cubo, Zebenzui Mendoza, Juan C. Martinez Castrillo, Pilar Sanchez Alonso, Maria G. Alonso Losada, Nuria Lopez Ariztegui, Itziar Gaston, Jaime Kulisevsky, Manuel Seijo, Caridad Valero, Ruben Alonso Redondo, Maria Teresa Buongiorno, Carlos Ordas, Manuel Menendez-Gonzalez, Darrian McAfee, Pablo Martinez-Martin, Pablo Mir, A. D. Adarmes, A. D. Adarmes, M. Almeria, M. G. Alonso Losada, A. Alonso Canovas, F. Alonso Frech, R. Alonso Redondo, I. alvarez, M. alvarez Sauco, A. Aneiros Diaz, S. Arnaiz, S. Arribas, A. Ascunce Vidondo, M. Aguilar, M. A. avila, N. Nernardo Lambrich, H. Bejr-Kasem, M. Blazquez Estrada, M. Boti, C. Borrue, M. T. Buongiorno, C. Cabello Gonzalez, I. Cabo Lopez, N. Caballol, A. Camara Lorenzo, H. Canfield Medina, E. Carabajal Pendon, F. Carrillo, F. J. Carrillo Padilla, E. Casas, M. J. Catalan, P. Clavero, A. Cortina Fernandez, M. Cosgaya, A. Cots Foraster, A. Crespo Cuevas, E. Cubo, T. de Deus Fonticoba, O. de Fabregues-Boixar, M. Diez-Fairen, J. Dotor Garcia-Soto, E. Erro, S. Escalante, EEstelrich Peyret, N. Fernandez Guillan, P. Gamez, M. Gallego, J. Garcia Caldentey, C. Garcia Campos, C. Garcia Diez, J. M. Garcia Moreno, I. Gaston, M. P. Gomez Garre, V. Gomez Mayordomo, J. Gonzalez Aloy, I. Gonzalez-Aramburu, J. Gonzalez Ardura, B. Gonzalez Garcia, M. J. Gonzalez Palmas, G. R. Gonzalez Toledo, A. Golpe Diaz, M. Grau Sola, G. Guardia, J. Hernandez Vara, A. Horta-Barba, DIdoate Calderon, J. Infante, S. Jesus, J. Kulisevsky, M. Kurtis, C. Labandeira, M. A. Labrador, F. Lacruz, M. Lage Castro, S. Lastres Gomez, I. Legarda, NLopez Ariztegui, L. M. Lopez Diaz, D. Lopez Dominguez, L. Lopez Manzanares, B. Lopez Seoane, S. Lucas del Pozo, Y. Macias, M. Mata, G. Marti Andres, M. J. Marti, J. C. Martinez Castrillo, P. Martinez-Martin, D. McAfee, M. T. Meitin, Z. Mendoza Plasencia, M. Menendez Gonzalez, C. Mendez del Barrio, P. Mir, J. Miranda Santiago, M. I. Morales Casado, A. Moreno Dieguez, I. Muro Garcia, V. Nogueira, A. Novo Amado, S. Novo Ponte, C. Ordas, J. Pagonabarraga, I. Parees, B. Pascual-Sedano, P. Pastor, A. Perez Fuertes, R. Perez Noguera, A. Planas-Ballve, L. Planellas, M. A. Prats, C. Prieto Jurczynska, V. Puente, M. Pueyo Morlans, A. Puig Davi, N. Redondo Rafales, L. Rodriguez Mendez, ABRodriguez Perez, F. Roldan, M. Ruiz De Arcos, J. Ruiz Martinez, P. Sanchez Alonso, M. Sanchez-Carpintero, G. Sanchez Diez, A. Sanchez Rodriguez, P. Santacruz, D. Santos Garcia, J. C. Segundo Rodriguez, M. Seijo, M. Sierra Pena, B. Solano Vila, E. Suarez Castro, J. P. Tartari, C. Valero, L. Vargas, L. Vela, C. Villanueva

Summary: This study aimed to analyze the change in cognitive function in patients with young-onset Parkinson's disease (YOPD) compared to those with a later onset and controls. The results showed that YOPD patients had better cognitive function compared to non-YOPD patients and controls, while non-YOPD patients experienced a significant decline in cognitive function during the study. At the end of the study, the incidence of dementia and mild cognitive impairment was significantly higher in non-YOPD patients than in YOPD patients.

JOURNAL OF NEUROLOGY (2023)

Add to Collection

Article Clinical Neurology

Quantification of Brain β-Amyloid Load in Parkinson's Disease With Mild Cognitive Impairment: A PET/MRI Study

Michela Garon, Luca Weis, Eleonora Fiorenzato, Francesca Pistonesi, Annachiara Cagnin, Alessandra Bertoldo, Mariagiulia Anglani, Diego Cecchin, Angelo Antonini, Roberta Biundo

Summary: This study investigated the impact of beta-amyloid (Aβ) on the clinical and cognitive manifestations as well as regional brain volumes in Parkinson's disease with mild cognitive impairment (PD-MCI). The results showed that the presence of Aβ worsened executive functions in PD-MCI patients, but did not affect motor and global cognitive abilities. Aβ deposition was found in specific brain regions, and higher amyloid load correlated with worse executive performances. However, Aβ may not be the main cause of cognitive deterioration in PD-MCI.

FRONTIERS IN NEUROLOGY (2022)

Add to Collection

Article Clinical Neurology

Neuropathological report of propionic acidemia

Ling-Xiao Cao, Wen-Zheng Hu, Wei Dong, Qing Yang, Jin-Hui Yin, Yue Wang, Xin Ni, Yue Huang

Summary: Propionic acidemia is a autosomal recessive metabolic disease that affects multiple systems of the human body. This study reports neuropathological findings in a patient with propionic acidemia. The patient presented with symptoms shortly after birth and died after complications from a liver transplantation. Postmortem examination revealed significant pathological changes in the brain.

NEUROPATHOLOGY (2023)

Add to Collection

Article Neurosciences

Motor cortical excitability and pre-supplementary motor area neurochemistry in healthy adults with substantia nigra hyperechogenicity

Gabrielle Todd, Caroline D. Rae, Janet L. Taylor, Nigel C. Rogasch, Jane E. Butler, Michael Hayes, Robert A. Wilcox, Simon C. Gandevia, Karl Aoun, Adrian Esterman, Simon J. G. Lewis, Julie M. Hall, Elie Matar, Jana Godau, Daniela Berg, Christian Plewnia, Anna-Katharina Von Thaler, Clarence Chiang, Kay L. Double

Summary: Research has found that increased thickness of the substantia nigra in healthy older adults may be associated with changes in excitability of motor cortical circuitry. This finding has important implications for understanding brain changes in healthy older adults at risk of Parkinson's disease.

JOURNAL OF NEUROSCIENCE RESEARCH (2023)

Add to Collection

Article Multidisciplinary Sciences

Evaluation of plasma levels of NFL, GFAP, UCHL1 and tau as Parkinson's disease biomarkers using multiplexed single molecule counting

Priscilla Youssef, Laura Hughes, Woojin S. Kim, Glenda M. Halliday, Simon J. G. Lewis, Antony Cooper, Nicolas Dzamko

Summary: Objective biomarkers for Parkinson's Disease (PD) could aid early and specific diagnosis, effective monitoring of disease progression, and improved design and interpretation of clinical trials. In this study, the potential of the SIMOA neurology 4-plex-A marker panel, along with plasma alpha-synuclein, as biomarkers for PD diagnosis and prognosis was assessed. The levels of NFL and GFAP in plasma positively correlated with alpha-synuclein levels, while as disease state biomarkers, NFL and GFAP showed correlation with motor severity and stage.

SCIENTIFIC REPORTS (2023)

Add to Collection

Article Multidisciplinary Sciences

Elevated GRO-alpha and IL-18 in serum and brain implicate the NLRP3 inflammasome in frontotemporal dementia

Hiu Chuen Lok, Jared S. Katzeff, John R. Hodges, Olivier Piguet, YuHong Fu, Glenda M. Halliday, Woojin Scott Kim

Summary: Neuroinflammation is a key feature of frontotemporal dementia (FTD), characterized by the degeneration of the frontal and temporal lobes. This study examined 48 cytokines in FTD serum and brain tissues to identify common dysregulation pathways. The results suggest the potential importance of the NLRP3 inflammasome in FTD.

SCIENTIFIC REPORTS (2023)

Add to Collection

Article Computer Science, Artificial Intelligence

Graph Fusion Network-Based Multimodal Learning for Freezing of Gait Detection

Kun Hu, Zhiyong Wang, Kaylena A. Ehgoetz Martens, Markus Hagenbuchner, Mohammed Bennamoun, Ah Chung Tsoi, Simon J. G. Lewis

Summary: This study proposes a multimodal learning-based FoG detection method using a graph fusion neural network (GFN) that combines footstep pressure maps and video recordings. The GFN constructs multimodal graphs to reduce redundancy among different modalities and achieves superior performance. Experimental results show promising FoG detection with an AUC of 0.882.

IEEE TRANSACTIONS ON NEURAL NETWORKS AND LEARNING SYSTEMS (2023)

Add to Collection

Review Neurosciences

Modulating arousal to overcome gait impairments in Parkinson's disease: how the noradrenergic system may act as a double-edged sword

Anouk Tosserams, Bastiaan R. Bloem, Kaylena Ehgoetz A. Martens, Rick C. Helmich, Roy P. C. Kessels, James M. Shine, Natasha L. Taylor, Gabriel Wainstein, Simon J. G. Lewis, Jorik Nonnekes

Summary: In stressful situations, individuals with Parkinson's disease (PD) may experience worsening of motor symptoms, including gait impairments. However, some patients report benefits from stressful or high-arousal situations. A study with 4324 PD patients shows that they use various mental strategies to cope with gait impairments, which can either increase or decrease overall sympathetic tone. This suggests that arousal can have both detrimental and alleviating effects on gait control in PD.

TRANSLATIONAL NEURODEGENERATION (2023)

Add to Collection

Review Biochemistry & Molecular Biology

Parkinson's disease: From genetics to molecular dysfunction and targeted therapeutic approaches

Yue Huang, Jun Wei, Antony Cooper, Margaret J. Morris

Summary: Parkinson's disease (PD) is a common neurodegenerative movement disorder in the elderly. The pathogenesis of PD is not fully understood, and there are currently no medications available to halt disease progression. Identification of causative genes and those associated with susceptibility to PD is crucial for the development of new therapeutic approaches. By reviewing relevant data, this study explores the roles of different genes and molecular pathways in the pathogenesis of PD, with the aim of improving consultation and personalized medicine for PD patients in the future.

GENES & DISEASES (2023)

Add to Collection

Article Biochemistry & Molecular Biology

Circadian clocks are modulated by compartmentalized oscillating translation

Yanrong Zhuang, Zhiyuan Li, Shiyue Xiong, Chujie Sun, Boya Li, Shuangcheng Alivia Wu, Jiali Lyu, Xiang Shi, Liang Yang, Yutong Chen, Zhangbin Bao, Xi Li, Chuhanwen Sun, Yuling Chen, Haiteng Deng, Tingting Li, Qingfeng Wu, Ling Qi, Yue Huang, Xuerui Yang, Yi Lin

Summary: Terrestrial organisms developed circadian rhythms to adapt to Earth's rotation. This study identified mammalian ATXN2 and ATXN2L as master regulators of rhythmic translation, achieved through oscillating phase separation in the suprachiasmatic nucleus. Depletion of ATXN2 or 2L alters the circadian period, while their absence disrupts translation activation cycles and weakens circadian rhythmicity in mice. This cellular defect can be rescued by wild type ATXN2, but not phase-separation-defective ATXN2.

CELL (2023)

Add to Collection

Article Neurosciences

The roles of apolipoprotein E ε4 on neuropathology and neuroinflammation in patients with Alzheimer′s disease

Mingyue He, Tenghong Lian, Peng Guo, Weijiao Zhang, Yanan Zhang, Yue Huang, Gaifen Liu, Huiying Guan, Jinghui Li, Dongmei Luo, Weijia Zhang, Wenjing Zhang, Jing Qi, Hao Yue, Xiaomin Wang, Wei Zhang

Summary: This study explores the roles of apolipoprotein E (APOE) epsilon 4 in the neuropathology and neuroinflammation of Alzheimer's disease (AD) patients. The study found that APOE epsilon 4 carriers had poorer cognitive function, lower levels of β amyloid protein (Aβ) 1-42, and higher levels of nitric oxide (NO).

CNS NEUROSCIENCE & THERAPEUTICS (2023)

Add to Collection

Article Clinical Neurology

Past antihypertensive medication use is associated with lower levels of small vessel disease and lower A & beta; plaque stage in the brains of older individuals

Andrew J. Affleck, Perminder S. Sachdev, Glenda M. Halliday

Summary: This study examines the impact of antihypertensive medication use on the severity of neuropathological cerebrovascular disease in older individuals. The results suggest that antihypertensive medication use is associated with less severe white matter small vessel disease. However, there is no significant relationship between medication use and infarction, lacunes, or cerebral amyloid angiopathy. Antihypertensive medication use reduces white matter rarefaction and Aβ propagation through the brain, specifically in individuals with moderate to severe white matter small vessel disease.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Add to Collection

Article Behavioral Sciences

Understanding visual hallucinations: A new synthesis

Daniel Collerton, James Barnes, Nico J. Diederich, Rob Dudley, Dominic Ffytche, Karl Friston, Christopher G. Goetz, Jennifer G. Goldman, Renaud Jardri, Jaime Kulisevsky, Simon J. G. Lewis, Shigetoshi Naral, Claire O'Callaghan, Marco Onofrj, Javier Pagonabarraga, Thomas Parr, James M. Shine, Glenn Stebbins, John-Paul Taylor, Ichiro Tsuda, Rimona S. Weil

Summary: Despite years of research, it remains uncertain why people sometimes perceive things that aren't there. Eight models of complex visual hallucinations have been proposed since 2000, each based on different understandings of brain organization. To address this variability, researchers established an integrated Visual Hallucination Framework that aligns with current theories of veridical and hallucinatory vision, enabling a systematic investigation of the relationship between hallucination phenomenology and cognitive structures. The episodic nature of hallucinations suggests a complex relationship between state and trait markers, highlighting new avenues for research and potential approaches to treating distressing hallucinations.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2023)

Add to Collection

Article Cell Biology

A blood-based marker of mitochondrial DNA damage in Parkinson's disease

Rui Qi, Esther Sammler, Claudia P. Gonzalez-Hunt, Ivana Barraza, Nicholas Pena, Jeremy P. Rouanet, Yahaira Naaldijk, Steven Goodson, Marie Fuzzati, Fabio Blandini, Kirk I. Erickson, Andrea M. Weinstein, Michael W. Lutz, John B. Kwok, Glenda M. Halliday, Nicolas Dzamko, Shalini Padmanabhan, Roy N. Alcalay, Cheryl Waters, Penelope Hogarth, Tanya Simuni, Danielle Smith, Connie Marras, Francesca Tonelli, Dario R. Alessi, Andrew B. West, Sruti Shiva, Sabine Hilfiker, Laurie H. Sanders

Summary: Parkinson's disease (PD) is a common neurodegenerative movement disorder in which mitochondrial dysfunction plays a key role. This study developed a PCR-based assay called Mito DNADX to accurately quantify mitochondrial DNA (mtDNA) damage. The assay revealed increased mtDNA damage in peripheral blood cells from PD patients and those with a PD-associated mutation. In addition, it was found that LRRK2 kinase inhibitors could mitigate mtDNA damage in animal models and patient-derived cells. This study suggests that quantifying mtDNA damage may serve as a potential biomarker for PD and for assessing the effectiveness of LRRK2 kinase inhibitors.

SCIENCE TRANSLATIONAL MEDICINE (2023)

Add to Collection

Article Neurosciences

Live cell in situ lysosomal GCase activity correlates to alpha-synuclein levels in human differentiated neurons with LRRK2 and GBA1 mutations

Adahir Labrador-Garrido, Siying Zhong, Laura Hughes, Shikara Keshiya, Woojin S. Kim, Glenda M. Halliday, Nicolas Dzamko

Summary: This study utilized a GCase substrate probe and live cell imaging to measure lysosomal enzyme activity. The results showed heterogeneity in GCase activity among PD patients, and a significant inverse correlation between GCase activity and α-synuclein protein levels. These findings suggest the importance of GCase in PD, and demonstrate the utility of this live cell imaging assay for further research on GCase in PD.

FRONTIERS IN CELLULAR NEUROSCIENCE (2023)

Add to Collection

Article Neurosciences

Association between nutritional status and gait performance in Alzheimer's disease

Mingyue He, Tenghong Lian, Peng Guo, Yanan Zhang, Yue Huang, Jing Qi, Jinghui Li, Huiying Guan, Dongmei Luo, Zhan Liu, Weijia Zhang, Zijing Zheng, Hao Yue, Jing Li, Wenjing Zhang, Ruidan Wang, Fan Zhang, Xiaomin Wang, Wei Zhang

Summary: This study explored the nutrition and gait of AD patients and their relationship at different stages. It found that patients at the dementia stage had worse nutritional status and gait performance compared to those at the MCI stage. Poorer nutritional status was associated with higher gait variability in patients at the MCI stage and with poorer gait performance in patients at the dementia stage. Early identification and intervention of patients with nutritional risk or malnutrition may improve gait performance and reduce the risk of falling, cognitive decline, and mortality.

CNS NEUROSCIENCE & THERAPEUTICS (2023)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.